Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Aurobindo
Aurobindo
Activities:
Ingredients
X
LinkedIn
Trending Articles
Bevel edge or radius edge flat face tablets: Which is better for greater consumer acceptance?
Consumers and patients should perceive that their tablets are easy to swallow and devoid of any undesirable taste. Tablet manufacturers can influence acceptance of by producing...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Pharmaceutical
Indian pharma firms develop niche portfolios
They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical
Indian generic manufacturers aim to enter the Japanese market
The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Media
Aurobindo's generic drug for osteoporosis approved by US FDA
The global osteoporosis drugs market is seeing significant growth due to a rising geriatric population and changing lifestyles
Finance
Aurobindo and Glenmark to get inflow of foreign capital
Deals underscore the importance given by the Indian government to strengthening healthcare in the country, by ensuring availability of drugs to the population at reasonable prices
Finance
Aurobindo divests stake in Australian subsidiary
Company also reaches settlement with Plethico over Natrol acquisition
Regulatory
Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis
The capsules were manufactured at two plants in India
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
Syntheses that cut costs and boost yields
Reworking drug syntheses using cheaper or more environmentally friendly ingredients and catalysts can increase margins dramatically. Dr Sarah Houlton reports on recent successes
Subscribe now